MINIPRESS PFIZER 437 (Minipress 2 mg)
Generic Name: prazosin
Pill imprint MINIPRESS PFIZER 437 has been identified as Minipress 2 mg.
Minipress is used in the treatment of raynaud's syndrome; benign prostatic hyperplasia; high blood pressure; heart failure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Minipress 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- prazosin
- Imprint:
- MINIPRESS PFIZER 437
- Strength:
- 2 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00069-4370
- Inactive Ingredients:
- FD&C Blue No. 1
FD&C Red No. 3
D&C Red No. 28
FD&C Red No. 40
magnesium stearate
sodium lauryl sulfate
sucrose
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-1290 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about Minipress (prazosin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
